Cancer BiologybioRxivPreprint
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer
Jia J. Li, Alessandro Vasciaveo, Dimitrios Karagiannis…·Michael M. Shen
This study identifies NSD2 as a key driver of lineage plasticity and castration-resistance in neuroendocrine prostate cancer, showing its inhibition can restore sensitivity to AR inhibitors.
9 citations